跳至主要内容
临床试验/JPRN-UMIN000017064
JPRN-UMIN000017064已完成未知

Effect of Anagliptin and Sitagliptin on low-density lipoprotein cholesterol in patients with type 2 diabetes and cardiovascular risk factors: Randomized controlled trial - Randomized Evaluation of Anagliptin versus Sitagliptin On low-density lipoproteiN cholesterol in diabetes Trial

Institute for Clinical Effectiveness0 个研究点目标入组 300 人开始时间: 2015年4月8日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with type 1 diabetes 2) Patients with triglyceride equal to or greater than 400 mg/dL in the previous fasting measuments 3) Patients with pregnancy, possible pregnancy, or on breast-feeding 4) Patients with severe infections, perioperative status, or severe trauma 5) Patients with elevated creatinine (>=2.4 mg/dl for men; >=2.0 mg/dl for women) 6) Patients who were received glucagon-like peptide-1receptor agonists 7) Patients whom physician in charge considered inappropriate for the study

研究者

发起方
Institute for Clinical Effectiveness

相似试验